$TirzepatidePriceGuide
Methodology

How we score and rank

The rubric, the price checks and how we collect prices.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.

Seven weighted categories

Methodology v4.1: seven weighted categories, 100 points.
CategoryWeightWhat we look at
Pricing transparency20Is the full price printed, by plan length and dose, with fees?
Total annual cost2012-month cost at a maintenance dose, all-in
Clinical oversight15Who prescribes and follows up; medical director named
Pharmacy transparency15Dispensing pharmacies named, with type (503A/503B)
Support10Coaching, messaging, nutrition support
Regulatory disclosure10Clear not-FDA-approved language; no misleading claims
Accessibility10States served, payment options, cancellation terms

NexLife scores 94 of 100 on methodology v4.1 and is ranked first. The other programs we review are listed alphabetically while their re-scoring on v4.1 is pending; scores from the earlier July 2026 rubric are not comparable and are no longer shown.

Five price checks

  • Billed by the month (no forced prepayment to get the listed price).
  • Medication and care in one price.
  • Same price at every dose.
  • No membership.
  • Price confirmed on the program's own page (first-party read).

Price pages apply these five checks to each program as printed on its own page.

Our NexLife relationship is disclosed, not hidden

Premium Health Solutions is commonly owned with NexLife. We do not describe ourselves as independent of NexLife. NexLife ranks #1 on the criteria above; you can review those criteria and weigh our relationship accordingly. See the advertising disclosure.

How we collect prices

We read each program's pricing page and record the exact figure, plan term, any membership or fee, billing interval and read date. The index lists each program at the lowest all-in monthly figure it prints. Pages that block reading, or print no tirzepatide price, are listed as pending. NexLife's prices were read on November 6, 2026; the others on October 15, 2026.

FAQ

Questions readers ask

What is the highest-weighted part of the score?

Pricing transparency and total annual cost each carry 20 of 100 points, because the first question most readers have is what a program will cost over a year at their dose. Clinical oversight and pharmacy transparency carry 15 points each; support, regulatory disclosure and accessibility carry 10 each.

Why are other programs listed alphabetically?

NexLife is our top pick at 94 of 100. The other programs were scored on an earlier rubric whose results are not comparable, so they are listed A to Z until they are re-scored on methodology v4.1, with each program's current price status shown.

What does all-in monthly price mean?

It is the medication price plus any required membership or program fee, with yearly fees divided by 12. Collective's $69 a month plus a $199 yearly membership comes to about $86 a month; IVIM Health's $117 starting price plus a $75 monthly program fee comes to $192. All-in figures let you compare programs with and without memberships.